Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

UTHR – United Therapeutics Corporation

United Therapeutics Corporation
UTHR
$325.82
Name : United Therapeutics Corporation
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $14,696,632,320.00
EPSttm : 25.09
finviz dynamic chart for UTHR
United Therapeutics Corporation
$325.82
1.91%
$6.11

Float Short %

4.76

Margin Of Safety %

9

Put/Call OI Ratio

1.05

EPS Next Q Diff

0.71

EPS Last/This Y

1.24

EPS This/Next Y

0.74

Price

325.81

Target Price

402.09

Analyst Recom

1.75

Performance Q

3.14

Relative Volume

0.66

Beta

0.58

Ticker: UTHR




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08UTHR308.150.741.197080
2025-05-09UTHR301.70.7536.507250
2025-05-12UTHR310.790.766.747306
2025-05-13UTHR307.640.790.297439
2025-05-14UTHR299.620.790.357480
2025-05-15UTHR303.940.792.737499
2025-05-16UTHR305.070.790.187513
2025-05-19UTHR305.081.130.526104
2025-05-20UTHR309.621.120.226121
2025-05-21UTHR310.681.160.886090
2025-05-22UTHR308.761.162.716103
2025-05-23UTHR307.771.090.186295
2025-05-27UTHR314.981.090.246351
2025-05-28UTHR315.561.060.036458
2025-05-29UTHR320.680.9617.196826
2025-05-30UTHR318.390.950.936872
2025-06-02UTHR325.690.960.057486
2025-06-03UTHR324.481.0111.257361
2025-06-04UTHR324.081.032.007450
2025-06-05UTHR319.961.041.937494
2025-06-06UTHR324.821.050.197555
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08UTHR308.1125.879.927.38
2025-05-09UTHR301.4025.825.327.38
2025-05-12UTHR310.8025.8138.527.38
2025-05-13UTHR308.0725.852.727.38
2025-05-14UTHR299.5925.812.127.38
2025-05-15UTHR303.5825.899.827.38
2025-05-16UTHR305.2725.881.027.38
2025-05-19UTHR305.3125.871.227.38
2025-05-20UTHR309.5725.8101.627.38
2025-05-21UTHR309.8525.873.427.38
2025-05-22UTHR308.7925.865.327.38
2025-05-23UTHR307.6625.864.127.38
2025-05-27UTHR314.8425.8121.927.38
2025-05-28UTHR315.5125.876.127.38
2025-05-29UTHR320.5525.8104.827.68
2025-05-30UTHR318.8525.861.327.68
2025-06-02UTHR325.4525.8118.727.68
2025-06-03UTHR324.2025.863.227.68
2025-06-04UTHR324.0725.870.627.68
2025-06-05UTHR319.7125.443.627.68
2025-06-06UTHR325.8125.4110.927.68
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08UTHR-28.403.263.75
2025-05-09UTHR-26.773.263.75
2025-05-12UTHR-25.793.284.44
2025-05-13UTHR-25.793.284.44
2025-05-14UTHR-25.793.284.44
2025-05-15UTHR-20.633.284.47
2025-05-16UTHR-20.633.284.47
2025-05-19UTHR-25.794.634.44
2025-05-20UTHR-25.864.634.47
2025-05-21UTHR-20.024.634.47
2025-05-22UTHR-20.024.634.47
2025-05-23UTHR-19.584.634.47
2025-05-27UTHR-19.580.354.47
2025-05-28UTHR-19.000.354.76
2025-05-29UTHR-19.000.354.76
2025-05-30UTHR-19.640.354.76
2025-06-02UTHR-19.641.384.76
2025-06-03UTHR-19.751.384.76
2025-06-04UTHR-19.751.384.76
2025-06-05UTHR-19.751.384.76
2025-06-06UTHR-19.751.384.76
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

6.63

Avg. EPS Est. Current Quarter

7.06

Avg. EPS Est. Next Quarter

7.34

Insider Transactions

-19.75

Institutional Transactions

1.38

Beta

0.58

Average Sales Estimate Current Quarter

802

Average Sales Estimate Next Quarter

833

Fair Value

353.79

Quality Score

100

Growth Score

98

Sentiment Score

59

Actual DrawDown %

22

Max Drawdown 5-Year %

-32

Target Price

402.09

P/E

13

Forward P/E

11.08

PEG

2.1

P/S

4.91

P/B

2.16

P/Free Cash Flow

13.05

EPS

25.06

Average EPS Est. Cur. Y​

27.68

EPS Next Y. (Est.)

28.42

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

40.44

Relative Volume

0.66

Return on Equity vs Sector %

-6.3

Return on Equity vs Industry %

10

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.38

EBIT Estimation

110.9
United Therapeutics Corporation
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1305
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company involved in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. United Therapeutics Corporation was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
stock quote shares UTHR – United Therapeutics Corporation Stock Price stock today
news today UTHR – United Therapeutics Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch UTHR – United Therapeutics Corporation yahoo finance google finance
stock history UTHR – United Therapeutics Corporation invest stock market
stock prices UTHR premarket after hours
ticker UTHR fair value insiders trading